FDA 483 - Amnio Technology, LLC - August 29, 2022

Amnio Technology, LLC in Phoenix, AZ, was cited for significant deficiencies in its manufacturing processes and quality control systems for injectable amniotic products. Observations included a lack of validated production processes, inadequate stability data, and deficient complaint handling procedures, alongside a failure to report a serious adverse event to the FDA.